A Comparison of Fluticasone Propionate, 100µg Twice Daily, Administered Via a CFC and Non-CFC Propellant, HFA 134a, in Adult Patients with Asthma

Author： Stone D.W.G.  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.21, Iss.10, 2001-10, pp. : 695-703

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhaled Triamcinolone Acetonide HFA 450µg Twice Daily Compared with Beclomethasone Dipropionate CFC 500µg Twice Daily in Adults with Moderate Persistent Asthma

By Hardy P.  

Clinical Drug Investigation, Vol. 20, Iss. 1, 2000-07 ,pp. : 9-17

Adis International

Access to resources Recommend Favorite

Efficacy and Tolerability of a New Non-Extrafine Formulation of Beclomethasone HFA-134a in Patients with Asthma: Comparison with Beclomethasone CFC

By Rocca-Serra J.P.  

Clinical Drug Investigation, Vol. 22, Iss. 10, 2002-01 ,pp. : 653-665

Adis International

Access to resources Recommend Favorite

Salmeterol/Fluticasone Propionate via Diskus™ Once Daily versus Fluticasone Propionate Twice Daily in Patients with Mild Asthma not Previously Receiving Maintenance Corticosteroids

By Chuchalin Alexander  

Clinical Drug Investigation, Vol. 28, Iss. 3, 2008-01 ,pp. : 169-181

Adis International

Access to resources Recommend Favorite

Fluticasone propionate: once- vs twice-daily for asthma

By  

Inpharma, Vol. 1, Iss. 1477, 2005-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Once-Daily Fluticasone Propionate is as Effective as Twice-Daily Treatment in Stable, Mild-to-Moderate Childhood Asthma

By Ian G.C. Hodges  

Clinical Drug Investigation, Vol. 25, Iss. 1, 2005-01 ,pp. : 13-22

Adis International

Access to resources Recommend Favorite